88 results on '"Fadnes, Lars Thore"'
Search Results
2. The association of psychological distress and economic and health worries with tobacco smoking behavior during the COVID-19 pandemic: a two-year longitudinal cohort study
3. Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders
4. Update of statistical analysis plan for: Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)
5. Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications†
6. Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial
7. No effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders: results from a randomized controlled trial
8. Changes in Body Mass Index and Their Associations with Psychological Distress, Worries, and Emotional Eating during the COVID-19 Pandemic: A Norwegian Cohort Study
9. Drug Death-Bereaved Parents’ Perspectives on Family Interactions and Help Needs: A Qualitative Study
10. Needs for help and received help for those bereaved by a drug-related death: a cross-sectional study
11. Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
12. The association between psychological distress and alcohol consumption and physical activity: a population-based cohort study
13. Perceived Change in Quality of Life Related to Treatment of Hepatitis C Infection among People with Substance Use Disorder: A Qualitative Study
14. The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
15. Emotional Eating and Changes in High-Sugar Food and Drink Consumption Linked to Psychological Distress and Worries: A Cohort Study from Norway
16. Treatment of hepatitis C and changes in substance use – a qualitative study
17. Attention-deficit/hyperactivity disorder symptoms among patients receiving opioid agonist therapy: a Norwegian cohort study
18. Association between oral and general health related quality of life among Norwegian patients with substance use disorders in opioid agonist therapy
19. Experiences of Hope after Treatment of Hepatitis C Infection—A Qualitative Study
20. The social health domain of people bereaved by a drug-related death and associations with professional help: A cross-sectional study
21. Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway
22. The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: A randomized controlled trial
23. Integrated exercise program in opioid agonist therapy clinics and effect on psychological distress: Study protocol for a randomised controlled trial (BAReAktiv)
24. Integration of Smoking Cessation Into Standard Treatment for Patients Receiving Opioid Agonist Therapy Who Are Smoking Tobacco: Protocol for a Randomised Controlled Trial (ATLAS4LAR)
25. Cost-effectiveness of integrated treatment for hepatitis C virus among people who inject drugs in Norway: an economic evaluation of the INTRO-HCV trial
26. Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway
27. Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway
28. How can vegetarian and vegan diets promote good health?
29. 208:poster Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: an economic evaluation of the INTRO-HCV trial
30. Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up
31. Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations
32. Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
33. Facilitators for use of oral healthcare services among people with substance use disorders: a qualitative study in Norway
34. Increased Gaming During COVID-19 Predicts Physical Inactivity Among Youth in Norway—A Two-Wave Longitudinal Cohort Study
35. Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics Among People with Severe Substance Use Disorders: A Cohort Study from Western Norway
36. Risk of Relapse to Non-Opioid Addictive Substances Among Opioid Dependent Patients Treated with an Opioid Receptor Antagonist or a Partial Agonist: A Randomized Clinical Trial
37. The Role of Physical Activity in Opioid Substitution Therapy: A Systematic Review of Interventional and Observational Studies
38. Effectiveness and Safety of Low-Threshold Opioid-Agonist Treatment in Hard-To-Reach Populations with Opioid Dependence
39. Effects of Nutritional Interventions in Individuals with Chronic Obstructive Lung Disease: A Systematic Review of Randomized Controlled Trials
40. Prevalence and Correlates of Suicide Attempts in High-Risk Populations: A Cohort study among patients receiving opioid Agonist Therapy in Norway
41. The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse
42. Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020
43. Oral health related quality of life and reasons for non‐dental attendance among patients with substance use disorders in withdrawal rehabilitation
44. How the Norwegian population was affected by non-pharmaceutical interventions during the first six weeks of the COVID-19 lockdown
45. Caries experience by socio-behavioural characteristics in HIV-1-infected and uninfected Ugandan mothers – a multilevel analysis
46. Substance Use Among Patients Receiving Out- and Inpatient Dependence Care: a Prospective Norwegian Cohort Study From 2016 to 2020
47. Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals’ experiences
48. Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
49. Perceived consequences and worries among youth in Norway during the COVID-19 pandemic lockdown
50. Statistical Modeling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.